Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 6 of 6)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - ICO THERAPEUTICS INC. (ICO-V)9$25  View Abstract
21-Apr-14GlobalDataGlobalDataiCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile33$250  View Abstract
19-Apr-14Reuters Investment ProfileN/AiCo Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
25-Mar-14Edison Investment ResearchDr. Pooya Hemami, Christian GlennieICO THERAPEUTICS - CLOSING IN ON IDEAL PRIMARY ENDPOINT DATA2$10  View Abstract
20-Mar-14Streetwise ReportsHugh ClelandApply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland10$92  View Abstract
18-Mar-14GlobalDataGlobalDataiCo Therapeutics Inc. (ICO) - Financial Analysis Review44$125  View Abstract

Independent Reports (Showing 1 to 6 of 6)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - ICO THERAPEUTICS INC. (ICO-V)9$25View Abstract
21-Apr-14GlobalDataGlobalDataiCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile33$250View Abstract
19-Apr-14Reuters Investment ProfileN/AiCo Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
25-Mar-14Edison Investment ResearchDr. Pooya Hemami, Christian GlennieICO THERAPEUTICS - CLOSING IN ON IDEAL PRIMARY ENDPOINT DATA2$10View Abstract
20-Mar-14Streetwise ReportsHugh ClelandApply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland10$92View Abstract
18-Mar-14GlobalDataGlobalDataiCo Therapeutics Inc. (ICO) - Financial Analysis Review44$125View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.